Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

351 Press Releases
DateTitleCompany
21 Jul 15 America's Most-Preferred Bone Health Brand Launches New Caltrate® Bone & Joint Health Supplement Pfizer Inc.,
Published by
Business Wire
08 Jul 15 Pfizer’s Centers For Therapeutic Innovation And Jeffrey Modell Foundation Announce Collaboration to Help Advance Immunological Research Pfizer Inc.,
Published by
Business Wire
07 Jul 15 Pfizer Begins Phase 2b Study Of Its Investigational Multi-antigen Staphylococcus aureus Vaccine In Adults Undergoing Elective Spinal Fusion Surgery Pfizer Inc.,
Published by
Business Wire
02 Jul 15 Pfizer Announces FDA Acceptance for Review of New Drug Application for A Once-Daily Formulation of XELJANZ® (tofacitinib citrate) Modified Release Tablets Pfizer Inc.,
Published by
Business Wire
25 Jun 15 Pfizer Declares 28-Cent Third-Quarter 2015 Dividend Pfizer Inc.,
Published by
Business Wire
25 Jun 15 Joseph J. Echevarria Elected To Pfizer’s Board Of Directors Pfizer Inc.,
Published by
Business Wire
24 Jun 15 CDC Advisory Committee on Immunization Practices Votes to Recommend Serogroup B Meningococcal Disease Vaccination including TRUMENBA® for Adolescents and Young Adults 16 through 23 Years of Age Pfizer Inc.,
Published by
Business Wire
23 Jun 15 Pfizer Announces Enrollment Of First Patient In Phase 3 Trial In Sickle Cell Disease Pfizer Inc.,
Published by
Business Wire
23 Jun 15 Pfizer Invites Public To View And Listen To Webcast Of July 28 Conference Call With Analysts Pfizer Inc.,
Published by
Business Wire
22 Jun 15 Pfizer Enters Into Agreement To Acquire Nimenrix And Mencevax From GlaxoSmithKline Pfizer Inc.,
Published by
Business Wire
15 Jun 15 Pfizer Consumer Healthcare To Expand Caltrate And Centrum Production In China Pfizer Inc.,
Published by
Business Wire
08 Jun 15 Pfizer Announces 12 Presentations Including New Research Data on Tofacitinib for Chronic Plaque Psoriasis and Atopic Dermatitis at World Congress of Dermatology Pfizer Inc.,
Published by
Business Wire
04 Jun 15 Get Ready. Get Set. Get Old. Pfizer Challenges Conventional Views of Aging through New Campaign Pfizer Inc.,
Published by
Business Wire
30 May 15 Pfizer Announces Palbociclib More Than Doubled Progression-Free Survival in Phase 3 Trial for Patients With HR+ HER2- Metastatic Breast Cancer Whose Disease Has Progressed Following Endocrine Therapy Pfizer Inc.,
Published by
Business Wire
29 May 15 Pfizer’s RAPAMUNE® (sirolimus) Becomes First FDA-Approved Treatment for Lymphangioleiomyomatosis (LAM) A Rare Progressive Lung Disease Pfizer Inc.,
Published by
Business Wire
28 May 15 Pfizer Global Survey Finds Adults with Rheumatoid Arthritis Who Feel Comfortable Speaking Up About Their Concerns Have a More Positive View of Their Health Pfizer Inc.,
Published by
Business Wire
28 May 15 Pfizer Announces $3 Million Grants Program to Further Clinical Research in Advanced Breast Cancer Pfizer Inc.,
Published by
Business Wire
21 May 15 America's Most-Preferred Multivitamin Brand Launches New Centrum® MultiGummies Pfizer Inc.,
Published by
Business Wire
19 May 15 Pfizer Invites Public to View and Listen to Webcast of June 2 Conference Call with Analysts to Review Oncology Business and ASCO Data Presentations Pfizer Inc.,
Published by
Business Wire
14 May 15 Pfizer Receives Request For Additional Information From FTC Regarding Proposed Acquisition Of Hospira Pfizer Inc.,
Published by
Business Wire
14 May 15 Marc Tessier-Lavigne Ph.D. to Leave Pfizer Board of Directors Pfizer Inc.,
Published by
Business Wire
14 May 15 Merck KGaA Darmstadt Germany and Pfizer to Present Data at ASCO for Avelumab an Investigational Anti-PD-L1 Antibody Pfizer Inc. and Merck KGaA, Darmstadt, Germany,
Published by
Business Wire
06 May 15 Pfizer Appoints New Leaders for BioTherapeutics Research & Development and Rinat Pfizer Inc.,
Published by
Business Wire
21 Apr 15 Pfizer Receives U.S. FDA Breakthrough Therapy Designation For XALKORI® (crizotinib) For The Treatment Of Patients With ROS1-Positive Non-Small Cell Lung Cancer Pfizer Inc.,
Published by
Business Wire
20 Apr 15 Global Strategic Partners Merck KGaA Darmstadt Germany and Pfizer Initiate Phase III Study with Avelumab* in Patients with Stage IIIb/IV Non-Small Cell Lung Cancer Pfizer Inc.,
Published by
Business Wire
16 Apr 15 Pfizer Invites Public to Listen to Webcast of April 23 Annual Meeting of Shareholders Pfizer Inc.,
Published by
Business Wire
16 Apr 15 Pfizer Launches 2014 Integrated Annual Review Pfizer Inc.,
Published by
Business Wire
15 Apr 15 Pfizer Announces PALOMA-3 Trial For IBRANCE® (Palbociclib) Stopped Early Due To Efficacy Seen In Patients With HR+ HER2- Metastatic Breast Cancer Whose Disease Has Progressed Following Endocrine Therapy Pfizer Inc.,
Published by
Business Wire
09 Apr 15 Pfizer Launches First Annual PCSK9 Competitive Grants Program to Advance Cardiovascular Disease Research Pfizer Inc.,
Published by
Business Wire
06 Apr 15 Kathrin U. Jansen Ph.D. to Lead Pfizer’s Vaccine Research and Development Unit Pfizer Inc.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.